Csenge Advisory Group’s BioTelemetry, Inc. BEAT Stock Holding History

Csenge Advisory Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,454	Closed	-$216K	–	224
2019 Q1	$216K	Buy	+3,454	New	+$237K	0.07%	183
2018 Q4	–	Sell	-10	Closed	–	–	1839
2018 Q3	$0	Buy	+10	New	+$558	﹤0.01%	1883

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Csenge Advisory Group's BEAT Position: Q2 2019 in Review

Csenge Advisory Group sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 3,454 shares — an estimated $216K sold.

Csenge Advisory Group first reported a position in BEAT in Q3 2018 and held it in 2 quarters. The position peaked at $216K in Q1 2019. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Csenge Advisory Group reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Csenge Advisory Group sold 3,454 BioTelemetry, Inc. shares in Q2 2019, an estimated $216K.
Csenge Advisory Group first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 2 quarters.
Csenge Advisory Group's BioTelemetry, Inc. position peaked at $216K in Q1 2019.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Csenge Advisory Group's 13F filing for Q2 2019, filed 30 Jul 2019.